JPMorgan Chase & Co. set a €95.60 ($113.81) target price on Fresenius Medical Care AG & Co. (Pref) (ETR:FME) in a research report released on Wednesday. The firm currently has a buy rating on the stock.

A number of other brokerages also recently commented on FME. Independent Research set a €90.00 ($107.14) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a neutral rating in a research note on Thursday, January 4th. UBS Group set a €87.00 ($103.57) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a neutral rating in a research note on Thursday, January 4th. Morgan Stanley set a €90.00 ($107.14) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a neutral rating in a research note on Monday, December 11th. Berenberg Bank set a €95.60 ($113.81) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a research note on Wednesday, December 6th. Finally, S&P Global set a €95.00 ($113.10) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a research note on Monday, November 6th. Ten research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company has a consensus rating of Hold and a consensus price target of €90.17 ($107.34).

Fresenius Medical Care AG & Co. (FME) opened at €89.36 ($106.38) on Wednesday. The company has a market capitalization of $27,530.00 and a price-to-earnings ratio of 21.90. Fresenius Medical Care AG & Co. has a 52 week low of €74.43 ($88.61) and a 52 week high of €92.50 ($110.12).

ILLEGAL ACTIVITY WARNING: “Fresenius Medical Care AG & Co. (Pref) (FME) PT Set at €95.60 by JPMorgan Chase & Co.” was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was stolen and republished in violation of international copyright and trademark legislation. The legal version of this story can be viewed at https://www.watchlistnews.com/fresenius-medical-care-ag-95-60-by-jpmorgan-chase-co/1805291.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.